Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study
Open Access
- 2 September 2019
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Health Care and Sciences
- Vol. 5 (1) , 1-7
Abstract
There is a lack of evidence that multidrug use triggers adverse events. Therefore, the main purpose of this study was to clarify the relationship between the total number of drugs and number of high-risk prescriptions administered to Japanese elderly patients. Using hospital electronic medical records (EMR), we evaluated the prescriptions of outpatients aged 65 years or older. We defined prescriptions of potentially inappropriate medications (PIMs) and overlapping prescription of drugs with the same mechanism of action (DSAs) as high-risk prescriptions. We analyzed the relationship among total number of drugs and high-risk prescriptions. In addition, we performed a secondary research to determine whether the hospitalization rate and concomitant medication contents differ depending on the high-risk prescriptions. Data for 13,630 outpatients were analyzed. A significant positive correlation between the numbers of total drugs and PIMs was found. The prescription frequency of individual PIMs rose as the total number of prescription drugs increased. The odds ratio (OR) of overlapping DSAs was significantly higher in patients using 5 or more drugs. In addition, there were significantly more prescriptions of laxatives among patients with overlapping prescriptions of anticholinergic drugs. The use of almost all PIMs was not an independent risk factor for hospitalization; instead, the number of PIMs was an independent risk factor for hospitalization [OR 1.18 (95% CI, 1.12–1.26)]. The number of PIMs and overlapping DSAs were high in patients receiving multidrug treatment. To avoid adverse events and hospitalization, it might be useful to review prescriptions and consider the number of PIMs and overlapping DSAs.Keywords
Funding Information
- Japan Society for the Promotion of Science (18H00428)
- Japan Agency for Medical Research and Development (JP18dk0207027h0003)
This publication has 24 references indexed in Scilit:
- Potential drug–drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in BrazilJournal of Psychiatric and Mental Health Nursing, 2017
- Screening Tool for Older Persons’ Appropriate Prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the elderly”Geriatrics & Gerontology International, 2016
- American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2015
- Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature reviewEuropean Journal of Clinical Pharmacology, 2015
- Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature reviewBritish Journal of Clinical Pharmacology, 2015
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 2Age and Ageing, 2014
- Adverse drug events in the outpatient setting: an 11‐year national analysisPharmacoepidemiology and Drug Safety, 2010
- Factors associated with adherence to medication regimens in older primary care patients: The steel valley seniors surveyThe American Journal of Geriatric Pharmacotherapy, 2008
- STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validationInt. Journal of Clinical Pharmacology and Therapeutics, 2008
- Polypharmacy and Prescribing Quality in Older PeopleJournal of the American Geriatrics Society, 2006